Pharmaceuticals Top 5 Emerging Markets Industry Guide 2015-2024
- Pages: 150
- Published: June 2020
- Report Code: MLIG200014-05
The Emerging 5 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Essential resource for top-line data and analysis covering the emerging five pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.
Key Highlights
– These countries contributed $214.1 billion to the global pharmaceuticals industry in 2019, with a compound annual growth rate (CAGR) of 6.6% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $291.7 billion in 2024, with a CAGR of 6.4% over the 2019-24 period.
– Within the pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of $142.6 billion in 2019. This was followed by India and Brazil with a value of $32.5 and $29.6 billion, respectively.
– China is expected to lead the pharmaceuticals industry in the top five emerging nations, with a value of $206.3 billion in 2024, followed by India and Brazil with expected values of $38.6 and $35.7 billion, respectively.
Scope
– Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five pharmaceuticals market
– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five pharmaceuticals market
– Leading company profiles reveal details of key pharmaceuticals market players’ emerging five operations and financial performance
– Add weight to presentations and pitches by understanding the future growth prospects of the emerging five pharmaceuticals market with five year forecasts
– Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
Reasons to buy
- What was the size of the emerging five pharmaceuticals market by value in 2019?
- What will be the size of the emerging five pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the emerging five pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the emerging five pharmaceuticals market?
Companies mentioned
Adcock Ingram Holdings Ltd
Aspen Pharmacare Holdings Ltd
Sanofi SA
Novartis AG
EMS Sigma Pharma
Ache Laboratorios Farmaceuticos SA
Yangtze River Pharmaceutical Group
Shanghai Pharmaceutical Co Ltd
Guangzhou Pharmaceuticals Corp
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Lupin Ltd
Sun Pharmaceutical Industries Inc
Dr. Reddy's Laboratories Limited
Aurobindo Pharma Ltd
Bayer AG
Pfizer Inc.
Merck & Co., Inc.
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.